Guidelines for the Quality Control of Population Pharmacokinetic-Pharmacodynamic Analyses: an Industry Perspective

被引:25
|
作者
Bonate, P. L. [1 ]
Strougo, A. [2 ]
Desai, A. [1 ]
Roy, M. [1 ]
Yassen, A. [2 ]
van der Walt, J. S. [2 ]
Kaibara, A. [3 ]
Tannenbaum, S. [1 ]
机构
[1] Astellas Pharma Global Dev, Northbrook, IL 60062 USA
[2] Astellas Pharma Global Dev, NL-2353W Leiderdorp, Netherlands
[3] Astellas Pharma Inc, Itabashi Ku, Tokyo 1748612, Japan
来源
AAPS JOURNAL | 2012年 / 14卷 / 04期
关键词
modeling; NONMEM; quality assurance; VALIDATION; MODEL;
D O I
10.1208/s12248-012-9387-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quality population modeling and simulation analyses and reports are something every modeler desires. However, little attention in the literature has been paid to what constitutes quality regarding population analyses. Very rarely do published manuscripts contain any statement about quality assurance of the modeling results contained therein. The purpose of this manuscript is to present guidelines for the quality assurance of population analyses, particularly with regards to the use of NONMEM from an industrial perspective. Quality guidelines are developed for the NONMEM installation itself, NONMEM data sets, control streams, output listings, output data files and resultant post-processing, reporting of results, and the review processes. These guidelines were developed to be thorough yet practical, though are not meant to be completely comprehensive. It is our desire to ensure that what is reported accurately reflects the collected data, the modeling process, and model outputs for a modeling project.
引用
收藏
页码:749 / 758
页数:10
相关论文
共 50 条
  • [1] Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective
    P. L. Bonate
    A. Strougo
    A. Desai
    M. Roy
    A. Yassen
    J. S. van der Walt
    A. Kaibara
    S. Tannenbaum
    The AAPS Journal, 2012, 14 : 749 - 758
  • [2] Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint
    Duffull, Stephen B.
    Wright, Daniel F. B.
    Winter, Helen R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) : 807 - 814
  • [3] Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's Perspective
    Jamsen, Kris M.
    McLeay, Sarah C.
    Barras, Michael A.
    Green, Bruce
    CLINICAL PHARMACOKINETICS, 2014, 53 (02) : 111 - 122
  • [4] A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
    Ari Brekkan
    Luis Lopez-Lazaro
    Gunnar Yngman
    Elodie L. Plan
    Chayan Acharya
    Andrew C. Hooker
    Suresh Kankanwadi
    Mats O. Karlsson
    The AAPS Journal, 20
  • [5] Population pharmacokinetic-pharmacodynamic analysis of givinostat
    Fiorentini, Francesco
    Germani, Massimiliano
    Del Bene, Francesca
    Pellizzoni, Cinzia
    Cazzaniga, Sara
    Rocchetti, Maurizio
    Bettica, Paolo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (04) : 229 - 238
  • [6] A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
    Brekkan, Ari
    Lopez-Lazaro, Luis
    Yngman, Gunnar
    Plan, Elodie L.
    Acharya, Chayan
    Hooker, Andrew C.
    Kankanwadi, Suresh
    Karlsson, Mats O.
    AAPS JOURNAL, 2018, 20 (05):
  • [7] Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
    Siripuram, Vijay K.
    Wright, Daniel F. B.
    Barclay, Murray L.
    Duffull, Stephen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (05) : 415 - 423
  • [8] Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients
    Mentré, F
    Pousset, F
    Comets, E
    Plaud, B
    Diquet, B
    Montalescot, G
    Ankri, A
    Mallet, A
    Lechat, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (01) : 64 - 78
  • [9] Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships for Docetaxel
    René Bruno
    Nicole Vivier
    Christine Veyrat-Follet
    Guy Montay
    Gerald R. Rhodes
    Investigational New Drugs, 2001, 19 : 163 - 169
  • [10] An Approach for Identifiability of Population Pharmacokinetic-Pharmacodynamic Models
    Shivva, V.
    Korell, J.
    Tucker, I. G.
    Duffull, S. B.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (06):